Theaflavin-3, 3′-digallate induces epidermal growth factor receptor downregulation
- 13 December 2005
- journal article
- research article
- Published by Wiley in Molecular Carcinogenesis
- Vol. 45 (3) , 204-212
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Epigallocatechin-3-gallate Inhibits Epidermal Growth Factor Receptor Signaling PathwayJournal of Biological Chemistry, 2004
- Epidermal Growth Factor Receptor Down-regulation Induced by UVA in Human Keratinocytes Does Not Require the Receptor Kinase ActivityJournal of Biological Chemistry, 2003
- Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasiaSeminars in Oncology, 2002
- Threonine Phosphorylation Diverts Internalized Epidermal Growth Factor Receptors from a Degradative Pathway to the Recycling EndosomeJournal of Biological Chemistry, 2000
- The extracellular-signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cellsOncogene, 1999
- Protective Role of Black Tea against Oxidative Damage of Human Red Blood CellsBiochemical and Biophysical Research Communications, 1998
- Inhibition of carcinogenesis by tea: The evidence from experimental studiesCritical Reviews in Food Science and Nutrition, 1997
- Ultraviolet B-induced Activated Protein-1 Activation Does Not Require Epidermal Growth Factor Receptor but Is Blocked by a Dominant Negative PKCλ/ιJournal of Biological Chemistry, 1996
- Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated from green teaNutrition and Cancer, 1996
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995